A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.
Rachael Zimlich, RN, BSN
A new vaccine in development could provide increased flu protection for seniors.
It’s too early yet to say whether last year’s devastating flu season will motivate more patients to receive flu shots, but so far it looks like a good year for the vaccine.
NasoVax is still in the development stages but may eventually provide an option for patients who are immunocompromised.
A new one-dose antiviral—the first treatment approved to fight the flu in 20 years—will be available to clinicians this flu season.
College students who never received the HPV vaccine series are interested in getting the shot on campus, according to a new study. The study is a reminder, according to the authors, to physicians that it’s never too late to offer the series to young adults.